miRNAs as modulators of neuroinflammation and excitotoxicity: Implications for stroke therapeutics
Pathology - Research and Practice,
Год журнала:
2024,
Номер
253, С. 155093 - 155093
Опубликована: Янв. 1, 2024
Язык: Английский
The emerging role of miRNAs in myocardial infarction: From molecular signatures to therapeutic targets
Pathology - Research and Practice,
Год журнала:
2024,
Номер
253, С. 155087 - 155087
Опубликована: Янв. 1, 2024
Язык: Английский
Exploring ferroptosis and miRNAs: implications for cancer modulation and therapy
Molecular and Cellular Biochemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 27, 2025
Язык: Английский
Comprehension of PTEN-Regulated MicroRNA Profiling in Oral Premalignant Lesions: A Critical Link to Early Detection of Oral Squamous Cell Carcinoma
Cureus,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 16, 2025
Язык: Английский
The potential relevance of long non-coding RNAs in colorectal cancer pathogenesis and treatment: A review focus on signaling pathways
Pathology - Research and Practice,
Год журнала:
2023,
Номер
253, С. 155044 - 155044
Опубликована: Дек. 20, 2023
Язык: Английский
Harnessing the power of miRNAs: The molecular architects of asthma pathogenesis and potential targets for therapeutic innovation
Pathology - Research and Practice,
Год журнала:
2023,
Номер
253, С. 155054 - 155054
Опубликована: Дек. 22, 2023
Язык: Английский
Unveiling the regulatory role of miRNAs in stroke pathophysiology and diagnosis
Pathology - Research and Practice,
Год журнала:
2024,
Номер
253, С. 155085 - 155085
Опубликована: Янв. 1, 2024
Язык: Английский
The potential role of miRNAs in the pathogenesis of schizophrenia – A focus on signaling pathways interplay
Pathology - Research and Practice,
Год журнала:
2024,
Номер
254, С. 155102 - 155102
Опубликована: Янв. 9, 2024
Язык: Английский
LncRNA HOXA‑AS2 is a prognostic and clinicopathological predictor in patients with cancer: A meta‑analysis
Tijun Xiao,
Yan An,
Lifang Tan
и другие.
Oncology Letters,
Год журнала:
2024,
Номер
27(5)
Опубликована: Март 22, 2024
Elevated
expression
of
long
non-coding
RNA
homeobox
A
cluster
antisense
2
(lncRNA
HOXA-AS2)
is
known
to
have
prognostic
value
in
various
solid
tumors.
The
present
meta-analysis
aimed
comprehensively
quantify
its
significance
across
a
wider
spectrum
malignancies
and
provide
an
updated
synthesis
evidence
that
could
refine
models.
To
achieve
this
aim,
multiple
databases
were
carefully
searched
for
lncRNA
HOXA-AS2-related
articles
published
the
past
10
years.
Hazard
ratios
(HRs)
or
odds
(ORs)
with
95%
confidence
intervals
(CIs)
calculated
demonstrate
HOXA-AS2
using
Stata
15.0
software.
function
was
inferred
from
associations
key
clinical
outcomes
such
as
lymph
node
metastasis,
distant
tumor
stage
size,
which
may
reflect
role
biology.
In
systematic
review
454
patients
7
studies,
it
found
high
significantly
associated
shorter
overall
survival
(OS)
time
cancer
(HR=2.14;
CI,
1.40-3.27;
P<0.001).
High
also
metastasis
[odds
ratio
(OR)=2.06;
1.07-3.99;
P=0.032],
(OR=2.11;
1.15-3.88;
P=0.016),
advanced
(OR=2.71;
1.50-4.89;
P=0.001)
larger
size
(OR=2.02;
0.86-4.78;
P=0.006).
However,
no
significant
association
observed
age
(OR=1.00;
0.63-1.59;
P=0.991)
sex
(OR=1.55;
0.72-3.34;
P=0.258).
conclusion,
elevated
related
poor
types,
osteosarcoma,
non-small
cell
lung
papillary
thyroid
carcinoma,
finding
further
confirmed
by
study.
Specifically,
potential
lncRNAHOXA-AS2
biomarker
assessing
stage,
risk
OS
demonstrated.
results
study
indicated
not
sex,
suggesting
progression
might
be
independent
these
factors.
This
insight
direct
future
research
place
more
focus
on
relationship
between
specific
types
characteristics.
Язык: Английский